Baicalin is reported to be compound with a crucial role in the treatment of cancer-induced bone pain, via the upregulation of transient receptor potential vanilloid 1 (TRPV1), thus preventing the progression of bone pain in cancer [26]. This evidence concerns the gene TRPV1 and cancer.